(Q39563888)

13 September 2017

1 reference

title

Asbestos-related malignancy (English)

1 reference

13 September 2017

1 reference

Talcott JA

1

1 reference

13 September 2017

Antman KH

series ordinal

2

1 reference

13 September 2017

publication date

1 May 1988

1 reference

Current Problems in Cancer

13 September 2017

published in

1 reference

13 September 2017

volume

12

1 reference

13 September 2017

issue

3

1 reference

13 September 2017

page(s)

135-178

1 reference

Occupational exposure to asbestos: population at risk and projected mortality--1980-2030

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

The pathogenesis of asbestos-associated diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Experimental Production of Mesothelial Tumours of the Pleura by Implantation of Dusts in Laboratory Animals

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Carcinogenicity of fibrous glass: pleural response in the rat in relation to fiber dimension.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

The effects of the inhalation of asbestos in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Oncogenic transformation with radiation and chemicals

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Comparative epidemiology of men exposed to asbestos and man-made mineral fibers

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

The occurrence of asbestosis among insulation workers in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Asbestos Hazards in Naval Dockyards

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Mortality experience of insulation workers in the United States and Canada, 1943--1976

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Lymphoid and Plasma Cell Malignancies: Asbestos-related Disorders of Long Latency

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Does asbestos exposure cause gastrointestinal cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Asbestos as a systemic carcinogen: the evidence from eleven cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Asbestos and laryngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Occupational asbestos exposure, smoking, and laryngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Abestos and laryngeal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Fiber counting and analysis in the diagnosis of asbestos-related disease

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Fiber concentration in lung tissue of patients with malignant mesothelioma. A case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

The effects of long-term ingestion of asbestos on the colon of F344 rats

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Epidemiology of mesothelioma from estimated incidence

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Non-occupational exposure to asbestos and malignant mesothelioma in females

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Household-contact asbestos neoplastic risk

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Mesothelioma after crocidolite exposure during gas mask manufacture

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Cancer in a factory using amosite asbestos

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Mortality experience of amosite asbestos factory workers: dose-response relationships 5 to 40 years after onset of short-term work exposure

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Asbestos Exposure, Smoking, and Neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Asbestos exposure, cigarette smoking and death rates

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Mechanisms of asbestos carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Relationship of mortality to measures of environmental asbestos pollution in an asbestos textile factory

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Asbestos in Schools — A Public Health Problem

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Asbestos as a public health risk: disease and policy

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

The occurrence of pleural calcification among asbestos insulation workers

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Ventilatory failure due to asbestos pleurisy

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Diffuse pleural thickening in asbestos workers: disability and lung function abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Diffuse pleural thickening in an asbestos-exposed population: prevalence and causes

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

The radiological manifestations of malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

A comparative study of mesothelioma and asbestosis using computed tomography and conventional chest radiography

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

The radiology of asbestos-induced disease of the lungs

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Prevalence and incidence of benign asbestos pleural effusion in a working population

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Asbestos pleural effusion

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Radiological features of diffuse mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Multimodality therapy for malignant mesothelioma based on a study of natural history

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

UICC-Cincinnati classification of the radiographic appearances of pneumoconioses. A cooperative study by the UICC committee

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Computed tomography of malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Occupational exposure and regional variation of malignant mesothelioma in Norway, 1970-79

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Recent trends in mesothelioma incidence in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Malignant mesothelioma in children: report of seven cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Malignant peritoneal mesotheliomas: a clinicopathological analysis of 12 fatal cases

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Diffuse Malignant Mesothelioma of the Pleura: A Review of 37 Cases

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

CT of peritoneal mesothelioma: analysis of eight cases

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Diffuse malignant mesothelioma. Prospective evaluation of 69 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Malignant mesothelioma of the pleura: a study of 52 treated and 64 untreated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Malignant mesothelioma: prognostic variables in a registry of 180 patients, the Dana-Farber Cancer Institute and Brigham and Women's Hospital experience over two decades, 1965-1985

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Malignant mesothelioma of the pleura: review of 123 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Primary malignant mesothelial tumors in Canada, 1960-1968. A pathologic review by the Mesothelioma Panel of the Canadian Tumor Reference Centre

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Carcinomatous involvement of the pleura: an analysis of 96 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Metastatic carcinoma of the pleura

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Comparison of tumour markers in malignant mesothelioma and pulmonary adenocarcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Absence of carcinoembryonic antigen-like material in mesotheliomaAn immunohistochemical differentiation from other lung cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

An ultrastructural comparison of mesotheliomas with adenocarcinomas of the lung and breast

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Surgical management of malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Diffuse, mixed malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Indications for pleurectomy in malignant effusion

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Early peritoneal mesothelioma: a treatable malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Malignant mesothelioma. The University of Minnesota experience

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Long-term survival in patients with malignant peritoneal mesothelioma treated with irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Chemotherapy of malignant diffuse mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Chemotherapy of diffuse malignant mesothelioma. Phase II trials of single-agent 5-fluorouracil and adriamycin

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Malignant mesothelioma. The Eastern Cooperative Oncology Group (ECOG) experience

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Treatment of diffuse pleural malignant mesothelioma by cis dichloro diammine platinum (C.D.D.P.) in nine patients

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Chemotherapy of malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

High-dose methotrexate with citrovorum factor and vincristine in the treatment of malignant mesothelioma.

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Treatment of six cases of mesothelioma with doxorubicin and cisplatin

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Chemotherapy of sarcomas with a combination of adriamycin and dimethyl triazeno imidazole carboxamide

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Chemotherapy for malignant mesothelioma; CAMEO

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

The value of adriamycin in the treatment of diffuse malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: a Sarcoma Intergroup Study

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Cisplatin administered by the intracavitary route as treatment for malignant mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

The acquired immunodeficiency syndrome (AIDS) as an occupational disease

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Asbestos-related diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Asbestos-associated diseases. Science, public policy, and litigation

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Untangling causation issues in law and medicine: hazardous substance litigation

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

Asbestos and lung cancer: an analysis of the epidemiological evidence on the asbestos-smoking interaction

1 reference

https://api.crossref.org/works/10.1016%2FS0147-0272%2888%2980005-9

7 January 2021

10.1016/S0147-0272(88)80005-9

Identifiers

DOI

1 reference

13 September 2017

1 reference